Log in here

Having issues with the members-only log-in? Try this!




NASEMSO Spring 2016 Meeting

Apr. 4-6, 2016
Bethesda, Maryland


NASEMSO Fall 2016 Meeting & Exhibit

Sept. 19-23, 2016
Albuquerque, New Mexico


The Washington Update

April 2016 (PDF)
Subscribe to receive the Washington Update via email


State EMS Job Board

Learn about State EMS job opportunities or request that your job listing be posted


The Ebola Virus: Preparedness & Response


Military Medic to Paramedic EMS Bridge Programs Webinar


Calendar of EMS Industry Events


Search Our Site


E-mail your questions or suggestions about our web site


NASEMSO Internet Policies


NASEMSO News 2016

News Archives: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

NPHL Posts 50-State Compilation of State Laws Addressing Epi-Pen Use in Schools

(02/01/16) Most states have laws and policies on food allergy management in schools that include guidelines for the administration of epinephrine. A new 50-State Compilation from the Network for Public Health Law (NPHL) provides a summary of the state laws addressing EpiPen use in schools. The NPHL is comprised of federal, tribal, state and local public health agencies and officials; public health attorneys; public health advocacy organizations and individual advocates; public health researchers and organizations; policy-makers (including elected and appointed officials); and other organizations or individuals committed to using the law to improve public health. Details


NAEMSP Posts Toolkit for Supporters of H.R. 4365: Protecting Patient Access to Emergency Medications Act of 2016

(01/20/16) The Protecting Patient Access to Emergency Medications Act of 2016 (H.R. 4365) was introduced Jan. 12, 2016, by Rep. Richard Hudson (R-NC). H.R. 4365 would codify the practice of allowing EMS providers to administer controlled substances per standing order by a physician medical director. In addition, it would allow the EMS agency to register for the DEA number, rather than rely on the physician medical director’s DEA registration. Download bill text here. On Jan. 20, the National Association of EMS Physicians posted a toolkit to encourage grassroots support of H.R. 4365, in order to gain co-sponsors and support for the bill. The toolkit, available here, provides a sample letter, talking points, a fact sheet, and contact information for the health care legislative aid for each office.

CAAS Achieves ANSI-Accredited Standards Developer Status

(01/12/16) The Commission on Accreditation of Ambulance Services (CAAS) on Jan. 11 announced that it has achieved accreditation from the American National Standards Institute (ANSI) for its standards development program. Mark Postma, CAAS Chair, said, "We are incredibly proud of this achievement which demonstrates CAAS's ongoing commitment to quality and excellence in standards development."

ANSI fosters the U.S. standardization system by accrediting the procedures of standard-setting organizations and subsequently approving individual documents as American National Standards (ANS). More than 230 ANSI-Accredited Standards Developers are now engaged in the creation and maintenance of voluntary consensus standards that are being used in virtually every industry sector. As an ANSI-Accredited Standards Developer, CAAS may now submit its standards for approval as American National Standards (ANS).

Questions about ANSI accreditation can be directed to the Procedures and Standards Administration department at psa@ansi.org. Learn more about CAAS at www.caas.org.

AAP Releases Policy Statement on Medical Countermeasures for Children in Public Health Emergencies, Disasters or Terrorism

(01/05/16) The American Academy of Pediatrics (AAP) has issued a new policy statement, “Medical Countermeasures for Children in Public Health Emergencies, Disasters or Terrorism.” This policy statement provides recommendations to close the remaining gaps for the development and use of MCMs in children during public health emergencies or disasters. Children are a population highly vulnerable to the effects of exposure to such threats, because many vaccines and pharmaceuticals approved for use by adults as MCMs do not yet have pediatric formulations, dosing information, or safety information. The abstract is available on the AAP website, and the full PDF is posted here.